Carbocyclic deazaadenosine
Alternative Names: C3D; DeazaasteromycinLatest Information Update: 05 Jan 2001
At a glance
- Originator Southern Research Institute
- Class Antivirals; Nucleosides; Small molecules
- Mechanism of Action Adenosylhomocysteinase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ebola virus infections; HIV infections; Parainfluenza virus infections; Respiratory syncytial virus infections
Most Recent Events
- 05 Jan 2001 Discontinued-Preclinical for Ebola virus infections in USA (Unknown route)
- 05 Jan 2001 Discontinued-Preclinical for HIV infections treatment in USA (Unknown route)
- 05 Jan 2001 Discontinued-Preclinical for Parainfluenza virus infections in USA (Unknown route)